Table 2.
Causes of Death in Placebo‐ and Zoledronic Acid–Treated Patients
| Zoledronic acid, N = 1054 | Placebo, N = 1057 | P valuea | |
|---|---|---|---|
| All causes (%) | 101 (9.6) | 141 (13.3) | 0.01 |
| Cardiac | 36 (3.4) | 52 (4.9) | 0.10 |
| Infectious | 18 (1.7) | 14 (1.3) | 0.48 |
| Respiratory | 13 (1.2) | 22 (2.1) | 0.17 |
| Neoplasms | 7 (0.7) | 13 (1.2) | 0.26 |
| Cerebrovascular | 10 (1.0) | 11 (1.0) | 1.00 |
| Gastrointestinal | 2 (0.2) | 4 (0.4) | 0.69 |
| Cachexia/failure to thrive | 1 (0.1) | 1 (0.1) | 1.00 |
| Renal | 1 (0.1) | 3 (0.3) | 0.62 |
| Other vascular | 3 (0.3) | 3 (0.3) | 1.00 |
P value based on Fisher's exact test.